产品详情
简单介绍：
Anti-INPP5F抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-INPP5F抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-INPP5F
Cat. Number:
Anti-INPP5F抗体KL-11256R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The inositol polyphosphate 5-phosphatases selectively remove the phosphate from the 5-position of various phosphatidylinositols,
Anti-INPP5F抗体which generate second messengers in response to extracellular signals. OCRL1 is a type II 5-phosphatase that is mutated in the oculocerebrorenal syndrome of Lowe (OCRL). OCRL is a rare X-linked disorder that is characterized in part by congenital cataracts, mental retardation, muscular hypotonia, and renal tubular dysfunction. OCRL1 has a high affinity for phosphatidylinositol 4,5-bisphosphate as well as inositol 1,4,5-trisphosphate, and inositol 1,3,4,5-tetrakisphosphate as substrates. OCRL1 is localized to the Golgi complex and is thought to be part of the trans-Golgi network (TGN), which suggests that OCRL1 plays a role in protein sorting and trafficking within the cell.
Also known as:
Inositol polyphosphate 5 phosphatase OCRL 1; Inositol polyphosphate 5 phosphatase OCRL1; Inositol polyphosphate 5-phosphatase
Anti-INPP5F抗体OCRL-1; INPP5F; LOCR; Lowe oculocerebrorenal syndrome protein; NPHL2; OCRL; OCRL_HUMAN; OCRL1; EC 3.1.3.36; Oculocerebrorenal syndrome of Lowe; Phosphatidylinositol polyphosphate 5 phosphatase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, GPV, Monkey, ,mk.
●
Immunogen: KLH conjugated synthetic peptide derived from human INPP5F.
●
Predicted Molecular Weight: 104kDa.
Anti-INPP5F抗体
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Anti-INPP5F抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl309Bo01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ca01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Hu01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Mu01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Po01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ra01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl310Bo01 载脂蛋白H(APOH)多克隆抗体 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Ca01 载脂蛋白H(APOH)多克隆抗体 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Hu01 载脂蛋白H(APOH)多克隆抗体 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Mu01 载脂蛋白H(APOH)多克隆抗体 Polyclonal Antibody to Apolipoprotein H (APOH)
kl310Ra01 载脂蛋白H(APOH)多克隆抗体 Polyclonal Antibody to Apolipoprotein H (APOH)
kl312Hu01 半乳糖凝集素12(GAL12)多克隆抗体 Polyclonal Antibody to Galectin 12 (GAL12)
kl312Mu01 半乳糖凝集素12(GAL12)多克隆抗体 Polyclonal Antibody to Galectin 12 (GAL12)
kl314Cp01 半乳糖凝集素14(GAL14)多克隆抗体 Polyclonal Antibody to Galectin 14 (GAL14)
